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Bedside Test Can Identify Clopidogrel Nonresponders
at Increased Risk for Periprocedural Myocardial Infarction
Wide interindividual variability is reported for the efficacy of clopidogrel. Pattiand colleagues prospectively correlated apoint-of-caremeasurement of residual
platelet reactivity with clinical outcome in 160 patients receiving clopidogrel before
percutaneous coronary intervention. All patients received a 600-mg loading dose 6 h
prior to the procedure orwere chronically using 75mgper day.The quartile of patients
with the least inhibition of platelet reactivity was at a 6-fold increased risk of 30-day
major adverse cardiac events. This rapid point-of-care assay of clopidogrel efficacymay
identify patients in whommore aggressive antithrombotic strategies are needed during
coronary intervention. See page 1128.
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Lipid Reduction Therapy
No Evidence That Statins Cause Cancer
Epidemiologic studies have shown higher rates of cancer in patients with lowcholesterol, prompting a concern that statins may increase the risk of cancer.
Alsheikh-Ali and colleagues pooled data from15 trials with over 400,000 patient-years
of follow-up. There was a correlation between lower low-density lipoprotein choles-
terol (LDL-C) and incident cancer in both statin- and placebo-treated subjects. The
slopes of the regression lines for both groups were similar, meaning that statin-treated
patients had lower levels of LDL-Cat similar levels of cancer risk.These findings donot
support a link between cancer and statin therapy, despite the LDL-C lowering. See
page 1141. See figure.
Heart Failure
Subclinical Thyroid Dysfunction May Increase Risk of HF
Subclinical thyroid dysfunction has been associated with cardiac dysfunction, butthe risk of incident heart failure (HF) has not been established. Rodondi and
colleagues reviewed data from adults age65 years who had baseline thyroid function
measured and were then followed for up to 12 years. Subclinical thyroid dysfunction
was defined as an elevated thyroid-stimulating hormone (TSH), but a normal free
thyroxine level. Participants with TSH10.0 mU/l were almost twice as likely to be
diagnosed with HF. These findings confirm that subclinical hypothyroidism predis-
poses to HF. See page 1152.
(continued) A-32Cardiac Imaging
MRI May Be Useful for Assessing Transplant CAD
Transplant coronary artery disease (TCAD) is a pan-arterial disease with diffuse,concentric intimal hyperplasia. The severity ofTCADmaybe underestimated by
traditional coronary angiography, which is more geared for the evaluation of focal
stenoses. Steen and colleagues compared contrast-enhancedmagnetic resonance imag-
ing (CE-MRI) with coronary angiography in 53 post-transplant patients. CE-MRI
enhancement patterns typical for infarctionwere seen in patients with TCAD, and the
likelihood of such findings increased as the severity of TCAD increased. There was no
association between TCAD and enhancement patterns that were atypical for infarc-
tions. Because nontransmural myocardial infarctions and diffuse coronary stenoses
may be missed using conventional coronary angiography, CE-MRI may be able to
establish an earlier diagnosis of TCAD. See page 1160.
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Aortic Diseases
CT Predicts Outcomes in Patients With Type B Dissections
The early mortality rate for type B aortic dissection ranges from 10% to 12%; thepreferred treatment for patients without complications is medical therapy, but
the potential complications may result in rapid death. Chang and colleagues reviewed
the computed tomography (CT) scans of 55 patients who were found to have acute
type B aortic dissections and were followed for in-hospital complications. The mean
maximal false lumen area (MFLA) and the number of branch vessels involved (BVI)
were found to be significant predictors of in-hospital complications. Patients
with initial MFLA 922 mm2 or BVI number 1 have a higher incidence of
in-hospital complications and may need earlier evaluation for surgical inter-
vention. See page 1170. See figure.
